Pap Smear News and Research

RSS

The Pap test, also called a Pap smear, checks for changes in the cells of your cervix. The cervix is the lower part of the uterus (womb) that opens into the vagina (birth canal). The Pap test can tell if you have an infection, abnormal (unhealthy) cervical cells, or cervical cancer.

For some refugees, women’s health care is a culture shock

Dinnertime is nearing, and the kitchen in this tidy home is buzzing. Lamyaa Manty, a 29-year-old Iraqi refugee, wears a neon-pink T-shirt and stirs a big pot of eggplant, onion, potatoes and tomatoes on the stove, a staple of Iraqi cooking called tepsi.

28 Sep 2017

Prevention experts propose easing advice on number of cervical cancer screenings

Don't get two when one will do. Instead of getting both a Pap test and an HPV test to screen for cervical cancer, many women should get just one or the other at regular intervals, according to a draft recommendation published this week by a panel of prevention experts.

15 Sep 2017

Alternative options could improve cervical cancer screening rate among transgender men, study shows

A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men.

8 Sep 2017

HPV testing leads to faster, more complete diagnosis of possible cervical precancer

Women who receive human papillomavirus testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical precancer, according to a study of over 450,000 women by Queen Mary University of London and the University of New Mexico Comprehensive Cancer Center.

22 Jun 2017

Duke University researchers develop handheld device for easier cervical cancer screening

Duke University researchers have developed a handheld device for cervical cancer screening that promises to do away with uncomfortable speculums and high-cost colposcopes.

31 May 2017

Researchers explore factors that influence patient's intent to get colorectal cancer screening

A patient's confidence in their ability to schedule, plan for and properly conduct their part in colorectal screening methods is a key factor that predicts whether they intend to be tested, according to new research from Penn State College of Medicine. The findings suggest that educating patients could improve screening rates.

30 Mar 2017

Cervical cancer death rate among older and black women higher than previously thought

A woman's risk of dying of cervical cancer is higher than long believed, particularly among older and black women, new Johns Hopkins Bloomberg School of Public Health-led research suggests.

23 Jan 2017

Johns Hopkins researchers develop new, highly accurate urine test to predict risk for cervical cancer

Johns Hopkins Medicine specialists report they have developed a urine test for the likely emergence of cervical cancer that is highly accurate compared to other tests based on genetic markers derived directly from cervical tissue.

17 Nov 2016

ASCO issues new global guideline on screening for cervical cancer

The American Society of Clinical Oncology today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.

14 Oct 2016

Pap tests may be beneficial for preventing cervical cancer in older women

A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.

21 Jul 2016

Routine Pap smear screenings linked to lower cervical cancer risk in older women

A new study from the University of Illinois confirms a link between routine Pap smear screenings and a lower risk of developing cervical cancer in women over age 65.

8 Jul 2016

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.

From QIAGEN Manchester Limited 15 Jun 2016

UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

Cervical cancer is the fourth most frequently occurring cancer in women. Human papillomavirus (HPV) is present in 99 percent of cervical cancers and is considered to be their cause. While most HPV infections will clear naturally within a few years, there has been no treatment available to hasten or improve the chance of natural eradication.

31 Oct 2015

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

As part of Kaiser Permanente's culture of continuous improvement, the organization annually recognizes outstanding projects across the nation's largest integrated health system that advance quality and patient safety. Recently, three winners were honored for their efforts in supporting patient care through technology, advanced sepsis intervention and improving early detection of diabetic retinopathy.

20 Oct 2015

New smartphone-based device can reliably perform molecular diagnoses at low cost

NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.

6 Oct 2015

NeoGenomics introduces new NeoSITE Cervical FISH assay

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its comprehensive FISH (Fluorescence In Situ Hybridization) testing menu to include a new NeoSITE Cervical assay to provide additional diagnostic information on abnormal Pap smears.

23 Sep 2015

Study reveals impact of patient navigator program on no-show rates for cervical cancer screening

Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20% decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient navigator program was initiated at the referral center.

25 Jul 2015

Findings could help improve patient care, reduce cancer screening costs around the world

A large clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa has found that contrary to expectations, a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained blood clots in their legs and lungs.

23 Jun 2015

Many transgender people refrain from going to health care providers to avoid social stigma

Discussing your sexual history with a doctor, or anyone for that matter, can be an uncomfortable experience. But for many transgender people, the conversation never takes place because they aren't seeking health care, according to Adrian Juarez, PhD, a public health nurse and assistant professor in the University at Buffalo School of Nursing.

27 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015